Skip to content

Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI)

Comparing The Performance Of Two Different Daily Disposable Lenses (MIKI)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04492397
Enrollment
35
Registered
2020-07-30
Start date
2020-09-30
Completion date
2021-03-31
Last updated
2021-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The objective of the study is to evaluate and compare the performance of study test lens to study control lens, when worn on a daily disposable modality over a period of approximately one week each

Detailed description

The study is a prospective, double masked (investigator and participant), bilateral, randomized,one week cross-over dispensing study, which evaluates the study test lens and control lens.

Interventions

Subjects will be randomized to wear test lenses.

Subjects will be randomized to wear control lenses.

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Is at least 17 years of age and has full legal capacity to volunteer; 2. Has read and signed an information consent letter; 3. Is willing and able to follow instructions and maintain the appointment schedule; 4. Habitually wears soft contact lenses in daily wear, for minimum of 6-months; 5. Is correctable to a visual acuity of 20/40 or better (in each eye) with the study lenses; 6. Has an astigmatism of ≤ 1.00 D in subjective refraction; 7. Can be fit with study contact lenses with a power between -2.00 and -5.00 DS; 8. Demonstrates an acceptable fit with the study lenses; 9. Habitually wears single vision soft contact lenses for at least 8 hours per day, 5 days a week, and is willing to wear contact lenses for at least 12 hours a day in the study.

Exclusion criteria

1. Is participating in any concurrent clinical or research study; 2. Has any known active\* ocular disease and/or infection; 3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable; 4. Is using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 5. Has known sensitivity to the diagnostic pharmaceuticals to be used in the study; 6. Is pregnant, lactating or planning a pregnancy at the time of enrolment because the associated hormonal changes cause changes in the tear layer which impact contact lens comfort. Verbal confirmation at the screening visit is sufficient; 7. Is aphakic; 8. Has undergone refractive error surgery; 9. Is an employee of the Centre for Ocular Research & Education; 10. Has participated in the BOXER (i.e. EX-MKTG-107, phases 1 or 2) or BASSET (EXMKTG-113) Study; 11. Has participated in any clinical trials within a week prior to the study.

Design outcomes

Primary

MeasureTime frameDescription
Overall Lens Fit Acceptance1 weekOverall fit acceptance (0-4, 0.50 steps) (0 - lens should not be worn at all,1 - Borderline but unacceptable, 2 - Minimally acceptable, 3 - Not perfect but OK to dispense, 4 - Perfect)

Secondary

MeasureTime frameDescription
Lens CentrationBaselineLens Centration was measured on a scale (0-3) (0 = Optimally centered, 1 = Slightly decentered, 2 = Moderate decentration but not encroaching limbus, 3 = Excessive & occasionally encroaching limbus)
Post-blink MovementBaselinePost-blink lens movement was measured using an eyepiece reticule while viewing the contact lens in-vivo at 8x magnification in primary gaze, in 0.1mm steps
Push-up TightnessBaselinePush-up tightness in primary gaze measured on a scale (0-100, 5% steps) (0% = falls from cornea without lid support, 50% = optimum, 100% = no movement)

Countries

Canada

Participant flow

Pre-assignment details

Forty-one subjects were screened and 35 subjects started and completed the study.

Participants by arm

ArmCount
Overall Study
Subjects will be randomized to wear control lenses and test lenses for one week. Contact lenses: Test Contact Lens Contact lenses: Control Contact Lens
41
Total41

Baseline characteristics

CharacteristicOverall Study
Age, Categorical
<=18 years
2 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
39 Participants
Age, Continuous25.8 years
STANDARD_DEVIATION 9.3
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Canada
41 participants
Sex: Female, Male
Female
31 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 350 / 35
other
Total, other adverse events
0 / 350 / 35
serious
Total, serious adverse events
0 / 350 / 35

Outcome results

Primary

Overall Lens Fit Acceptance

Overall fit acceptance (0-4, 0.50 steps) (0 - lens should not be worn at all,1 - Borderline but unacceptable, 2 - Minimally acceptable, 3 - Not perfect but OK to dispense, 4 - Perfect)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Test Contact LensOverall Lens Fit Acceptance3.71 units on a scaleStandard Deviation 0.33
Control Contact LensOverall Lens Fit Acceptance3.73 units on a scaleStandard Deviation 0.35
Secondary

Lens Centration

Lens Centration was measured on a scale (0-3) (0 = Optimally centered, 1 = Slightly decentered, 2 = Moderate decentration but not encroaching limbus, 3 = Excessive & occasionally encroaching limbus)

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Test Contact LensLens Centration0.40 units on a scaleStandard Deviation 0.5
Control Contact LensLens Centration0.29 units on a scaleStandard Deviation 0.52
Secondary

Lens Centration

Lens Centration was measured on a scale (0-3) (0 = Optimally centered, 1 = Slightly decentered, 2 = Moderate decentration but not encroaching limbus, 3 = Excessive & occasionally encroaching limbus)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Test Contact LensLens Centration0.17 units on a scaleStandard Deviation 0.38
Control Contact LensLens Centration0.20 units on a scaleStandard Deviation 0.47
Secondary

Post-blink Movement

Post-blink lens movement was measured using an eyepiece reticule while viewing the contact lens in-vivo at 8x magnification in primary gaze, in 0.1mm steps

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Test Contact LensPost-blink Movement0.20 mmStandard Deviation 0.06
Control Contact LensPost-blink Movement0.23 mmStandard Deviation 0.06
Secondary

Post-blink Movement

Post-blink lens movement was measured using an eyepiece reticule while viewing the contact lens in-vivo at 8x magnification in primary gaze, in 0.1mm steps

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Test Contact LensPost-blink Movement0.20 mmStandard Deviation 0.05
Control Contact LensPost-blink Movement0.23 mmStandard Deviation 0.07
Secondary

Push-up Tightness

Push-up tightness in primary gaze measured on a scale (0-100, 5% steps) (0% = falls from cornea without lid support, 50% = optimum, 100% = no movement)

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Test Contact LensPush-up Tightness51 units on a scaleStandard Deviation 5
Control Contact LensPush-up Tightness49 units on a scaleStandard Deviation 6
Secondary

Push-up Tightness

Push-up tightness in primary gaze measured on a scale (0-100, 5% steps) (0% = falls from cornea without lid support, 50% = optimum and 100% = no movement)

Time frame: 1 week

ArmMeasureValue (MEAN)Dispersion
Test Contact LensPush-up Tightness50 units on a scaleStandard Deviation 4
Control Contact LensPush-up Tightness48 units on a scaleStandard Deviation 4

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026